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Abstract 
Chitosan is a cationic polysaccharide that exhibits mucoadhesive properties which allow it to adhere 
to mucosal tissues. In this work, we explored chemical modification of chitosan through its reaction 
with methacrylic anhydride to synthesise methacrylated derivative with the aim to improve its 
mucoadhesive properties. The reaction products were characterised using 1H NMR, FTIR and UV-Vis 
spectroscopy. 1H NMR and ninhydrin test were used to quantify the degree of methacrylation of 
chitosan. Turbidimetric analysis of the effect of pH on aqueous solubility of the polymers revealed that 
the highly methacrylated derivative remained turbid and its turbidity did not change from pH 3 to 9. 
However, solutions of native chitosan and its derivative with low methacrylation remained 
transparent at pH 6.5 and exhibited a rapid increase in turbidity at pH > 6.5. The mucoadhesive 
properties of chitosan and its methacrylated derivatives were evaluated using flow-through method 
combined with fluorescent microscopy with fluorescein sodium as a model drug. The retention of 
these polymers was evaluated on porcine bladder mucosa in vitro. The methacrylated derivatives 
exhibited greater ability to retain fluorescein sodium on the bladder mucosa compared to the parent 
chitosan. Toxicological studies using MTT assay with UMUC3 bladder cells show no significant 
differences in toxicity between chitosan and its methacrylated derivatives suggesting good 
biocompatibility of these novel mucoadhesive polymers. 
 
2 
 
Keywords: Chitosan; Mucoadhesive; methacrylic anhydride; Intravesical drug delivery; UMUC3 cell; 
toxicity; Wash-out 50 
1. Introduction 
Ability of water-soluble polymers to adhere to mucosal surfaces, defined as mucoadhesion, has been 
exploited in the design of mucoadhesive drug delivery systems in the last decades. Various studies 
have reported the use of mucoadhesive polymers to improve drug delivery in the eye, the nasal cavity, 
the mouth, the vagina and the urinary bladder (Ludwig 2005; Andrews et al. 2009; Bernkop-Schnürch 
& Dünnhaupt 2012; Casettari & Illum 2014; Khutoryanskiy 2014; Sosnik et al. 2014; Kolawole et al. 
2017; Morales & Brayden 2017). Advantages of mucoadhesive delivery systems include improved drug 
bioavailability, non-invasive nature of dosage form administration and ease of their application, and 
the possibility of targeting specific organs, etc.  
Chitosan is a cationic polysaccharide that has been widely used in the design of dosage forms for 
transmucosal drug delivery due to its non-toxic nature and excellent mucoadhesive properties 
(Bernkop-Schnürch & Dünnhaupt 2012; Casettari & Illum 2014). Chitosan often exhibits superior 
mucoadhesive properties compared to many other water-soluble polymers; however, there is still a 
strong interest to improve its properties through chemical modification (Ways et al., 2018). Various 
dosage forms were developed using chitosan derivatives such as glycol chitosan, trimethyl chitosan, 
carboxymethyl chitosans, thiolated chitosans, half-acetylated chitosan, glycol chitosan-catechol, 
methylpyrrolidinone chitosan, and acrylated chitosan and they have all displayed improved retention 
on mucosal surfaces, thereby extending the duration of action of loaded therapeutics (Ways et al., 
2018). 
Over the last few years, acrylate- and maleimide-functionalised materials have been explored for 
transmucosal drug delivery due to their enhanced mucoadhesiveness compared to their parent 
polymers (Davidovich-Pinhas and Bianco-Peled, 2011; Tonglairoum et al., 2016; Eshel-Green and 
Bianco-Peled, 2016; Brannigan and Khutoryanskiy, 2017; Shitrit and Bianco-Peled, 2017; Shtenberg et 
al., 2017; Kaldybekov et al., 2018; Eliyahu, et al., 2018). This is achieved through the quick formation 
of covalent bonds between acrylate- or maleimide- groups of a mucoadhesive polymer and thiol-
groups present in cysteine-rich domains on mucosal surfaces.  
Methacrylate groups are also capable of forming covalent bonds with thiols under physiological 
conditions, similarly to acrylate groups and maleimide. A few studies exist where methacrylate groups 
have been conjugated to pharmaceutical materials for drug delivery and tissue engineering. For 
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example, Yu et al (2007) reported the development of methacrylated chitosan that was subsequently 
cross-linked by radical polymerisation to prepare biodegradable macroporous scaffolds for cell culture 
applications. Lin et al. (2013) reported the synthesis of methacrylated gelatin that was then used in 
mixtures with human endothelial colony-forming cells / mesenchymal stem cells for in vivo injection 
and transdermal photo-crosslinking. However, to our knowledge, the potential of methacrylated 
polymers as mucoadhesive materials has not been explored yet.  
In this study, we developed methacrylated derivatives by reacting chitosan with methacrylic anhydride 
and evaluated their physicochemical properties, in vitro adhesion to porcine urinary bladder mucosa 
and cytotoxicity in UMUC3 bladder cells to establish their suitability as materials for transmucosal 
delivery.  
2. Materials and methods 
2.1. Materials 
High molecular weight chitosan (CHI, 370 kDa; deacetylation degree 70.9 ± 2.2%), methacrylic 
anhydride (MA), ninhydrin, trifluoroacetic acid, citric acid, fluorescein sodium, FITC-Dextran (3-5 kDa), 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), foetal bovine serum (FBS) and 
UMUC3 malignant urothelial cells (Sigma-Aldrich UK); modified Eagle’s medium with Earle salts & non-
essential amino acids and trypsin-EDTA (Lonza UK); dialysis membrane with molecular weight cut off 
12-14 kDa (Medicell International UK); and most chemical reagents (Fischer Scientific UK) were used 
as received without further purification. Freshly excised porcine urinary bladders were received from 
PC Turner Abattoir (Farnborough, Hampshire, UK). 
 
2.2. Synthesis of methacrylated chitosan 
2.2.1. Synthesis of LMeCHI and HMeCHI 
Methacrylated chitosan was synthesised by reacting chitosan with methacrylic anhydride at various 
molar ratios (Table 1) to generate two types of products using the method developed in-house with 
slight modification (Sogias et al. 2010). 
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Fig. 1. Reaction scheme for the synthesis of methacrylated chitosan: CHI is a parent chitosan and LMeCHI and 
HMeCHI are chitosans with low and high degrees of methacrylation, respectively.  
 
Briefly, 1.5 % w/v chitosan solution (100 mL) was prepared by dissolving predetermined amount of 
chitosan in 4% v/v acetic acid at 25oC for 12 h. Various amounts of methacrylic anhydride were added 
slowly to chitosan solution and the mixture was maintained at 40oC, shaken at 60 rpm for 12 h, 
protected from light. The products were redispersed in deionised water, purified by dialysis (MWCO 
12-14 kDa membrane) against 4.5L deionised water with six water changes over 72 h. The final 
products were freeze-dried using Heto PowerDry LL3000 Freeze Dryer (Thermo Scientific, UK). 
 
Table 1: Feed ratios for the synthesis of LMeCHI and HMeCHI 
Parameters LMeCHI HMeCHI 
Concentration, chitosan  1.5 % (w/v) 1.5 % (w/v) 
Weight/volume of methacrylic anhydride 1.035g (1 mL) 6.21g (6mL) 
Moles of MA per unit mole CHI 0.79 4.65 
 
2.3. Characterisation of methacrylated chitosan 
2.3.1. 1 H Nuclear magnetic resonance spectroscopy (1 H NMR) 
Solutions of CHI, LMeCHI & HMeCHI (0.6% w/v) were prepared in D2O acidified with 30 µL 
trifluoroacetic acid and allowed to be dissolved overnight at room temperature. The 1H NMR spectra 
were recorded using 400 MHz ULTRASHIELD PLUS™ B-ACS 60 spectrometer (Bruker, UK). 
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2.3.2. Fourier Transform-Infrared Spectroscopy (FT-IR) 
Solid samples of modified and unmodified chitosan were scanned from 4000 to 400 cm-1, resolution 
of 4 cm-1. Data was processed based on the average of six scans per spectrum generated by the Nicolet 
iS5-iD5 ATR FT-IR spectrometer (Thermo Scientific, UK). 
2.3.3. Turbidimetric measurements 
The influence of pH on the turbidity of polymer samples was studied according to Sogias et al (2010) 
with slight modification. Briefly, polymer solutions were prepared in 0.1M acetic acid at room 
temperature with initial pH 3. NaOH solution (0.1 molL-1) was added to increase the pH stepwise and 
turbidity values of polymer dispersions were measured at 400 nm with Jenway 7315 UV-Vis 
spectrophotometer (Bibby Scientific, UK).  
     2.3.4. Zeta potential measurements 
Zeta potential values of CHI, LMeCHI and HMeCHI solutions/dispersions were determined in folded 
DTS-1070 capillary cell using Zetasizer Nano-ZS (Malvern Instruments, UK) at 25C. 
Solutions/dispersions of chitosan and derivatives (0.4 % w/v) were diluted 1: 20 with ultrapure water  
prior to analysis. The machine was operated at a refractive index of 1.59 and an absorbance of 0.01. 
Triplicate readings were recorded with 30 sub-runs per measurement. 
2.3.5. X-ray Diffractometry 
The influence of methacrylation on the crystallinity of chitosan was evaluated using wide-angle 
powder D8 Advance diffractometer/LYNXEYE XE detector (Bruker, UK). Solid samples of CHI, LMeCHI 
and HMeCHI were loaded into a capillary tube, sealed with wax to prevent loss and placed onto the 
goniometer and aligned under a microscope for diffraction analysis, scanning at diffraction ranges 
from 5 to 50o with a scan step of 0.02o, generating characteristic diffractograms at the rate of 2.5 scans 
min -1.  
2.3.6. Ninhydrin test to quantify methacrylate groups 
The amount of methacrylate groups conjugated to chitosan was quantified using previously published 
method with slight modification (Shitrit & Bianco-Peled 2017). Briefly, 2 % w/v solution of ninhydrin 
in DMSO was prepared by stirring for 12 h at room temperature in the dark. Unmodified and modified 
chitosan solutions (0.05 – 0.5% w/v) were prepared by dissolving in 0.1 M acetic acid, stirred for 18 h 
in the dark at 25oC. 5mL of ninhydrin solution and 1.25 mL of 4M phosphate buffer (pH 5.4±0.2) were 
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mixed with 0.5 mL polymer solution. The resultant mixtures were incubated in  a water bath at 85oC 
(OLS 200, Grant, UK) shaken at 60 rpm for 30 min. 1 mL of each mixture was analysed using Jenway 
7315 UV-Vis spectrophotometer (Bibby Scientific, UK) at 500 nm. 
2.4. Ex vivo Porcine mucoadhesion studies 
2.4.5. Preparation of polymer / fluorescein sodium mixture and artificial urine solution 
The polymeric solutions/dispersions of CHI, LMeCHI and HMeCHI were prepared by dissolving 
polymers in 0.1 M acetic acid and stirred overnight. Resultant polymer solutions/dispersions were 
mixed with 0.1% w/v fluorescein sodium to yield final polymer concentration of 0.4 % w/v (FS/CHI, 
FS/LMeCHI and FS/HMeCHI, respectively). FITC-dextran 0.4 % (w/v) was dissolved in deionised water 
overnight under dark conditions at room temperature to serve as negative control. 
A protocol developed by Chutipongtanate et al (2010) was used to prepare artificial urine. Briefly, the 
compounds (Table S1, Supplementary information) were stirred in deionised water for 3 h at room 
temperature, pH adjusted to 6.2 and made up to a final volume of 2L. 
2.4.6. Retention on porcine urinary bladder mucosa 
Fluorescence microscopy (MZ10F microscope (Leica Microsystems, UK), fitted with an “ET GFP” filter, 
a Zeiss Imager A1/AxioCam MRm camera; 1296 x 966 pixels; 0.8 x magnification) was used to evaluate 
the mucosal retention of fluorescein  sodium in the presence of the polymeric carriers based on a 
slightly modified protocol developed in-house (Mun et al. 2016). Freshly excised porcine urinary 
bladders stored on ice were used in this study within 24 h of procurement. The mucosal side of the 
bladder tissue was preserved during excision of the required section (about 1.5 x 2.5 cm) and rinsed 
with artificial urine solution (~ 3 mL) prior to blank tissue imaging. The bladder tissue was placed on a 
75 mm x 25 mm glass slide and maintained in an incubator at 37oC during urine wash-out. The 
following exposure times were used: FITC-dextran (80 ms), FS/CHI (211 ms), FS/LMeCHI and 
FS/HMeCHI (279 ms). Microscopic images were recorded for each tissue sections before and after 
applying 100 µL of the polymer sample as well as after each of the five washing cycles with 10 mL 
artificial urine / cycle at 2 mL/min. The studies were carried out in triplicates. Image J software  
(National Institute of Health, USA) was used to analyse the microscopic images, generating average 
fluorescence values as a function of urine volume used for the wash-out. In order to normalise the 
mean fluorescence values, fluorescence values obtained based on blank tissues were deducted from 
fluorescence values obtained after each wash-out cycle while the value “1” was used to depict the 
fluorescence intensity from the tissue prior to wash. From the wash-out trends of the polymers, the 
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WO50 values were determined using exponential or polynomial fit of the graphs (Figure S1, 
Supplementary information), which depicts the volume of artificial urine needed to wash out 50% of 
the polymer dispersion. 
2.5. Cell culture and viability experiment 
Human urothelial carcinoma cell line, UMUC3 cells (Sigma-Aldrich, UK)), were cultured in MEM 
supplemented with 10% FBS. The cells were cultured in an incubator maintained at 37oC containing 
5% CO2 atmosphere. MTT assay was used to evaluate cell viability with previously reported method 
with slight modification (Lau et al. 2011). Briefly, UMUC3 cells were seeded in 96-well plate at a density 
of 1 x 104 cells/well. After 24 hours, the cells were treated with polymer solution in growth medium 
(6.25 – 200 µg mL-1) for 4 h. The cells were allowed to grow for further 72 hours. After incubation 
period, 20 μL of MTT solution (5 mg mL-1) was added to each well. After 4 h, the supernatant was 
removed and 100 µL DMSO was added where absorbance was read using the microplate reader 
(Benchmark-BIO-RAD) at 570 nm. Untreated cells were used as positive control and culture medium 
was used as background control. Each concentration had three replicates in each experiment and all 
experiments were done in triplicate. The cell viability was evaluated as a function of viable cells post 
treatment and total untreated cells. The polymer concentration that yields half-maximum inhibitory 
response (IC50 value) was determined based on the best linear fit of the cell viability versus polymer 
concentration graph. 
2.6. Statistical analysis 
All experimental data were collected in triplicates and data expressed as average ± standard deviation. 
Data were compared using a one-way ANOVA with post-Bonferroni test using GraphPad Prism 5.04 
(GraphPad Software Inc., San Diego, California), with p < 0.05 depicting significant difference between 
data sets. 
3. Results and discussion 
Over the last decade, chitosan has been progressively explored for mucosal delivery of drugs and 
biotherapeutics due to its  biocompatibility, biodegradability, mucoadhesiveness and cell permeation 
enhancing features (Jayakumar et al. 2010). Recently, acrylated chitosan has been shown to have 
superior intestinal mucoadhesiveness relative to the thiolated analogue (Shitrit & Bianco-Peled 2017). 
The aim of this study was to synthesise methacrylated chitosan using an efficient single step chemical 
modification. Two types of methacrylated chitosan derivatives with different degrees of substitution 
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were synthesised and evaluated on their solubility at various pH, mucoadhesiveness and 
biocompatibility. These derivatives were prepared by the reaction of chitosan with methacrylic 
anhydride.  
3.3. Methacrylated chitosan derivatives synthesis 
The two methacrylated chitosan derivatives LMeCHI and HMeCHI were synthesised with a yield of 62 
% and 24 %, respectively (Table 2). There was no significant difference in their appearance being both 
off-white colour in nature. 
 
Table 2. Synthetic yield, physical properties and degree of methacrylation (using 1H NMR spectroscopy 
and ninhydrin test) of LMeCHI and HMeCHI 
Parameter 
LMeCHI HMeCHI 
Synthetic yield 62% (w/w) 24 % (w/w) 
Physical appearance 
Degree of methacrylation 
off-white solid off-white solid 
Degree of 
Methacrylation  
1H NMR 
 
11.2 ± 3.4 % 38.5 ± 3.9 % 
Ninhydrin 
test 
34.3 ± 2.0 % 55.4 ± 1.0% 
 
The 1H NMR spectra (Figure 2) show the distinctive peaks for chitosan at δ 2.0 ppm (-CH3 from 
acetylated part of chitosan) as well as 3.09 - 3.8 ppm representing protons from the glucosamine ring. 
With the methacrylated derivatives, additional peaks are evident at 5.6 and 6.2 ppm depicting the 
alkenyl double bond from the methacrylate moiety conjugated to chitosan. Also the additional peak 
at 1.84 ppm appeared in the spectra of methacrylated chitosan is due to CH3- of methacrylic groups. 
These spectral data are in good agreement with the report by Yu et al. (2007). 
 
The ratio of mean intensity of the proton peaks of the methacrylate groups (δ = 5.6 – 6.2 ppm) relative 
to that of the chitosan glucosamine protons δ = 3.0 – 3.8 ppm) provides their extent of methacrylation:  
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𝑀𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑖𝑜𝑛 (%) =
𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑙 𝑜𝑓 𝑚𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑒 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 𝑎𝑡 5.6 & 6.2 𝑝𝑝𝑚 /2
𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑙 𝑜𝑓 𝐻2−𝐻6  𝑝𝑟𝑜𝑡𝑜𝑛𝑠 /6
100%            (1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. 1H NMR spectra of CHI (1), LMeCHI (2) and HMeCHI (3) recorded in D2O acidified with 1% trifluoroacetic 
acid. H2-H6 protons of CHI were detected at 3.0-3.8 ppm (i) and vinyl groups of methacrylate segment evident 
around 5.6-6.2 ppm (ii). 
FT-IR shows characteristic absorption bands for chitosan (Fig. 3) at 1026-1151 cm-1 (amine C-N 
stretch). Since both chitosan and methacrylate groups display alkyl C-H stretch (2850 and 2930 cm-1), 
the increase in the intensity of the absorption bands is evident of the methacrylated products. The 
appearance of a new double bond signal  at  1537-1653 cm-1 depicted alkenyl C=C stretch, while  amide 
C=O stretch evident at 1635 cm-1 in LMeCHI and HMeCHI confirms the methacrylation of chitosan. The 
FT-IR spectrum of LMeCHI is similar to that of HMeCHI, but differs in terms of the intensity, which is 
related to their extent of methacrylation. 
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Fig.3. FT-IR spectra of CHI , HMeCHI and LMeCHI with characteristic peak at 1537-1635 cm-1 as well as 
1653 cm-1 for LMeCHI and HMeCHI depicting alkenyl C=C and amide C=O linkage between chitosan 
and methacrylate groups, respectively. 
 
3.4. Turbidimetric measurements  
The effects of pH on turbidity of polymers were analysed where unmodified chitosan shows a 
turbidity-pH profile (Figure 4) in good agreement with our previous report (Sogias et al, 2010): the 
solution remains transparent until the pH reaches 6.5; then a further increase in solution pH results in 
a dramatic increase in turbidity. LMeCHI sample exhibits a pH-dependent solubility similar to 
unmodified chitosan, with a sharp increase in turbidity observed at pH>6.5. On the other hand, the 
turbidity profile of HMeCHI is distinctly different, where a slightly turbid colloidal solution was formed 
at first and maintained in the studied pH range. This is likely to be due to the relatively hydrophobic 
nature of methacrylate groups that cause aggregation of chitosan macromolecules and formation of 
micellar structures. The solution of LMeCHI did not show any signs of turbidity at pH<6.5 possibly 
because its degree of methacrylation did not reach a certain threshold to become sufficiently 
hydrophobic to undergo aggregation. The relatively unchanged turbidity possibly relates to the 
disruption of semi-crystalline nature of chitosan caused by introduction of bulky methacrylate groups; 
similar effect was reported for half-acetylated chitosan (Sogias et al, 2010).  
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Fig.4. Effect of pH on solution turbidity of unmodified chitosan, LMeCHI and HMeCHI. Lines are used as guide to 
eye. 
  
3.5. X-ray Diffractometry 
The X-ray diffractogram (Figure 5) shows the unmodified chitosan exhibited two major peaks at 
diffraction angles (2θ) of 10.1 and 20.8o, which correlate with the peaks displayed by chitosan reported 
in our earlier publications (Yin et al. 2006; Luo et al. 2008; Sogias et al. 2010). X-ray diffractograms of 
LMeCHI and HMeCHI (Fig. 4) reveal a decrease in crystallinity upon methacrylation of chitosan with 
disappearance of the peak at 8.3 and broadening of the peak at 22.4o. This suggests that  chitosan 
has been successfully modified and the modification reduced the ability of chitosan macromolecules 
to form crystalline domains. This is in good agreement with our previous report on reduction of 
chitosan’s crystallinity upon its re-acetylation (Sogias et al. 2010).  
 
Fig. 5. X-ray diffractograms of CHI, LMeCHI and HMeCHI generated at 2.5 scansmin-1, scan angle 5-65o, scan step 
size of 0.02o, spectra offset for improved clarity. 
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3.6. Quantification of acrylate groups  
In addition to  1H NMR, the ninhydrin test was also used to confirm the degree of methacrylation, 
where ninhydrin reacts with the unmodified amine groups of chitosan to form a coloured product 
detectable by UV (Gohel et al. 2006). The slope of the adsorption versus concentration curve of 
unconjugated chitosan is represented as ɑCHI, while that of LMeCHI and HMeCHI are denoted as ɑMeCHI. 
Methacrylation percentage can be defined as (1 - ɑMeCHI/ ɑCHI) * 100 % (Shitrit & Bianco-Peled 2017).                                             
Table 2 provided data on the extent of methacrylation for LMeCHI and HMeCHI. The degrees of 
methacrylation for LMeCHI and HMeCHI, calculated from the ninhydrin test (34.3% vs. 55.4%, 
respectively), were greater than the values calculated using 1H NMR spectra (11.2% vs. 38.5%). This 
may be due to the differences in experimental design as the 1H NMR spectra of polymers were 
recorded in D2O, acidified with 1 % trifluoroacetic acid, whereas analysis with ninhydrin was 
performed with the samples dissolved in 0.1 M acetic acid. Different solvents used in these methods 
could affect the conformation of polymers and availability of functional groups. Potentially, 1H NMR 
technique could underestimate the degree of methacrylation because methacrylate groups could not 
be on the surface. Nevertheless, the data from both techniques reveal that HMeCHI had a greater 
degree of methacrylation than LMeCHI. 
3.7. Mucoadhesion studies 
In order to evaluate the mucosal retention, fluorescein sodium was added to the unmodified and 
methacrylated chitosan solutions prior to the experiment.  In the study, the unmodified chitosan, 
cationic in nature with proven mucoadhesive potential (Sogias et al. 2008), was chosen as the positive 
control, while dextran with limited mucoadhesiveness (Štorha et al. 2013) served as the negative 
control.  
The mucosal retention of CHI, LMeCHI and HMeCHI on ex vivo bladder tissue was quantified using 
numerical WO50 values (Mun et al. 2016). WO50 is defined as the volume of artificial urine required to 
remove 50 % of fluorescein sodium from the bladder mucosal surface. 
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Fig. 6 (a) Exemplar microphotographs showing FITC-Dextran, FS/CHI, FS/LMeCHI, and FS/HMeCHI wash-out from 
porcine urinary bladder with artificial urine solution over 5 washing cycles, scale bar is 2 mm; (b) Mucosal 
retention of fluorescein sodium (FS) from CHI, LMeCHI and HMeCHI on porcine urinary bladder tissue; FITC 
dextran served as negative control and FS/CHI (unmodified chitosan) as positive control. Result presented as 
mean ± standard deviation, n = 3, *depicts significant statistical differences between samples (p < 0.05). 
 
WO50 values for FS/CHI, FS/LMeCHI and FS/HMeCHI were 15 mL, 24 mL and 48 mL, respectively, 
suggesting that increased methacrylation confers greater mucoadhesive potential on chitosan. FITC-
dextran, serving as the negative control was the least retained on the porcine bladder mucosa, 
displays WO50 of 7 mL based on extrapolation as 10 mL of artificial urine was used for each wash-out 
cycle (Fig. 6) similar to that reported previously (Mun et al. 2016). The superior mucoadhesive 
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behaviour of HMeCHI as shown in Fig. 6 is likely due to the presence of higher percentage of 
unsaturated methacrylate groups that formed covalent bonds with thiols  of mucin present on the 
mucosal surface (Shitrit & Bianco-Peled 2017).  
The zeta potential of 13.3 ± 3.2, 41.4 ± 7.0 and 54.4 ± 1.9 mV were recorded for 0.02% w/v polymer 
solutions/dispersions of CHI, LMeCHI and HMeCHI, respectively. The degree of positive charge of these 
polymers supports their favourable interaction with the negatively charged mucosal surface 
(Khutoryanskiy, 2014). Moreover, the methacrylated chitosan may also facilitate loosening of tight 
junctions between cells which promotes cellular internalisation of the drug carrier (Smith et al. 2004). 
There was statistical difference in the mucoadhesive profile of parent chitosan and the highly 
methacrylated derivative (HMeCHI) after five washing cycles (p <0.05).  
Interestingly, HMeCHI displayed a similar WO50 value (48 mL) to PEGylated maleimide functionalised 
liposomes (WO50 value 48 mL) evaluated for bladder delivery (Kaldybekov et al. 2018), suggesting that 
functionalisation of chitosan with methacrylate moieties may facilitate comparable covalent 
interactions with mucosal glycoproteins, achievable with maleimide derivatisation of liposomes. 
3.8. Cell viability studies 
Distressing symptoms like painful sensation during urination are common in bladder cancer. So, drug 
carriers intended for bladder cancer therapy should not aggravate the discomfort experienced by 
patients. UMUC3   human bladder carcinoma cells have been used as in vitro model for studying the 
cytotoxic and irritation effect of drug delivery systems intended for bladder cancer treatment (Zhang 
et al. 2014; Lu et al. 2015; Lu et al. 2016). The selected duration of cell incubation with polymer 
solution (4 h) was clinically relevant as most drug carriers required such contact time with diseased 
tissues for effective therapy (Mugabe et al. 2011). The safety of methacrylated gellan gum has been 
previously reported (Coutinho et al. 2010), but there was no data available for methacrylated chitosan. 
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Fig.7. UMUC3 cell viability studies using CHI, LMeCHI and HMeCHI. Polymer treatment for 4 h and cell viability 
studied at 72 h post exposure to polymers. The untreated cells served as the control. Cell viability is normalised 
against the control; n=3. Lines are used as guide to eye. Error bars are not shown on this figure to avoid 
overcrowding. 
The UMUC3 cell growth inhibitory effect of the polymers was studied over 72 h (Fig. 7). CHI, LMeCHI 
and HMeCHI displayed IC50 values of 108.40 ± 5.81, 96.17 ± 5.27 and 104.16 ± 4.81µg mL-1, 
respectively. One-way ANOVA statistical analysis shows that there is no statistically significant 
differences in the IC50 values between all three polymers (p>0.05). This suggests the methacrylated 
chitosan is as safe as the unmodified chitosan and thus could be exploited further for intravesical drug 
delivery due to its superior mucoadhesive features. 
4. Conclusion 
To our knowledge, this is the first report where the pH-dependent solubility, mucoadhesive properties 
and safety profile of unmodified and methacrylated chitosan have been compared. Methacrylate 
groups were grafted onto chitosan through the reaction of its amino-groups with methacrylic 
anhydride in order to synthesise novel mucoadhesive polymers. The volume ratio of high molecular 
weight chitosan to methacrylic anhydride was varied to generate two types of methacrylated chitosan 
that differed in terms of their degree of methacrylation. 1H NMR and ninhydrin test analysis confirmed 
the successful synthesis of the methacrylated products.  
Methacrylation of chitosan has been identified as a simple and viable synthetic strategy to generate 
drug carriers with greater mucoadhesive properties. This novel drug carrier can be used to formulate 
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dosage forms that allows prolonging drug residence time in the bladder thereby improving extent of 
drug absorption thus therapeutic outcomes for bladder cancer treatment. Methacrylated chitosan 
with enhanced mucoadhesive properties could also be of interest for application in other areas of 
transmucosal drug delivery. Future research using these mucoadhesive chitosan derivatives may 
include preparation of formulations with various active pharmaceutical ingredients, studies of their 
physicochemical characteristics and drug release studies.  
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